soft-shell crab exportersoftshell crab exporterVietnam crab exporter

All News Johnson & Johnson In Focus Johnson & Johnson BreakingNews of Johnson & Johnson Your Interested Follow Story Johnson & Johnson

U.S. FDA panel recommends booster doses of Johnson & Johnsons COVID-19 vaccine
SATURDAY, OCTOBER 16, 2021
A U.S. FDA advisory committee voted unanimously to recommend authorization of a second dose of Johnson & Johnsons COVID-19 vaccine as early as two months after the primary shot for anyone aged 18 and older.
Johnson & Johnson seeks emergency authorization for coronavirus booster
WEDNESDAY, OCTOBER 06, 2021
WASHINGTON - Johnson & Johnson asked the Food and Drug Administration on Tuesday to grant emergency use authorization for a booster dose of its single-shot coronavirus vaccine, making it the final vaccine used in the United States for which permission is being sought for an extra shot.
Second dose of Johnson & Johnson vaccine increases protection against covid-19, maker says
WEDNESDAY, SEPTEMBER 22, 2021
WASHINGTON - A second shot of the Johnson & Johnson vaccine boosts protection against symptomatic and severe covid-19, the disease caused by the coronavirus, the drug company announced early Tuesday.
Govt calls in private sector to import 25m jabs as outbreak worsens
THURSDAY, AUGUST 05, 2021
Facing a Delta-driven outbreak of more than 20,000 cases daily, and barely 6 per cent of the population fully vaccinated, Thailand is finally handing its private sector the means to import vaccines directly.
Over 1m doses of J&J vaccine from US arrive in S. Korea
SUNDAY, JUNE 06, 2021
More than 1 million doses of Johnson & Johnsons Janssen COVID-19 vaccine arrived in South Korea from the United States on Saturday in what Seoul and Washington officials touted as a sign of the two countries robust alliance.
Johnson & Johnson documented contamination risks at Baltimore plant months before vaccine was ruined
THURSDAY, MAY 20, 2021
WASHINGTON - Johnson & Johnson documented contamination risks at a Baltimore biodefense plant in June 2020, seven months before a contamination problem ruined 15 million doses of coronavirus vaccine and derailed Johnson & Johnsons domestic vaccine production, according to documents disclosed Wednesday by a House panel investigating the incident.
Little concern about J&J vaccine nationwide
FRIDAY, APRIL 30, 2021
INDIANAPOLIS - A blue card sat on the windshield of Josh Woolvins black Hyundai Tucson on Tuesday, a spot of color in the sunshine at Indianapolis Motor Speedway. It signaled to nurses at this drive-by immunization clinic that Woolvin and his mother, Debbie Shipp, wanted Johnson & Johnsons single-dose coronavirus vaccine, not their other choice, Pfizer-BioNTechs two-shot regimen.
Federal agencies lift pause on use of Johnson & Johnson vaccine, saying benefits outweigh risks
SATURDAY, APRIL 24, 2021
Federal health officials lifted a pause on the use of the Johnson & Johnson coronavirus vaccine Friday night after an extensive safety review by the Centers for Disease Control and Prevention and the Food and Drug Administration.
Health officials lean toward resuming Johnson & Johnson coronavirus vaccine - but with a warning
FRIDAY, APRIL 23, 2021
Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood clots but probably not call for age restrictions.
Public health experts increase vaccine education during Johnson & Johnson pause
THURSDAY, APRIL 15, 2021
A day after federal agencies recommended a pause in administration of the Johnson & Johnson coronavirus vaccine while they investigate potential rare side effects, public health experts and providers in the Washington region on Wednesday said they are increasing education and transparency to allay potential worries among people about coronavirus vaccines.